stockrowElevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.
- Revenue
- +1.42%
- EPS
- +17.9%
- Free cash flow
- +29.0%
- Total debt
- −3.65%
Quarter to September 2026, against a year earlier
Follow ELV
Alert me
Elevance Health, Inc. (ELV) Revenue growth
Elevance Health, Inc.'s revenue growth over the twelve months to 30 September 2026 was 3.60%, down 8.9 percentage points from fiscal 2025 (12.5%). Over the past ten years it has ranged from 2.29% (fiscal 2018) to 16.9% (fiscal 2020); the current reading is higher than 64% of that period. That is below the Healthcare Plans industry median of 6.77% and below the Healthcare sector median of 7.98%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 12.5% | 9.18 |
| FY2024 | 3.31% | (6.11) |
| FY2023 | 9.42% | (3.53) |
| FY2022 | 13.0% | (0.81) |
| FY2021 | 13.8% | (3.18) |
| FY2020 | 16.9% | 3.79 |
| FY2019 | 13.2% | 10.86 |
| FY2018 | 2.29% | (3.81) |
| FY2017 | 6.10% | (1.11) |
| FY2016 | 7.21% | 0.06 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 1.42% | 0.02 |
| Jun 2026 | 1.40% | (1.24) |
| Mar 2026 | 2.64% | (6.83) |
| Dec 2025 | 9.47% | (2.96) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| OSCR Oscar Health, Inc. compare | 54.8% |
| HUM Humana Inc. compare | 22.0% |
| CNC Centene Corporation compare | 9.71% |
| CI Cigna Group compare | 6.80% |
| CVS CVS Health Corporation compare | 6.73% |
| PGNY Progyny, Inc. compare | 5.52% |
| ELV Elevance Health, Inc. | 3.60% |
| UNH UnitedHealth Group Incorporated compare | 3.33% |
| MOH Molina Healthcare, Inc compare | −0.95% |
| Healthcare Plans industry median | 6.77% |
| Healthcare sector median | 7.98% |
| Market median | 7.71% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ELV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement